2018
$50M
from 10 investors over 10 rounds
Casma Therapeutics raised $46M on November 15, 2022
Investors: Eventide Management Partners, Schroders Capital, Astellas Venture Capital L.L.C., The Column Group, Eisai Asia, Mirae Asset MAPS Global Investments Co., Ltd and Third Rock Ventures
Casma Therapeutics raised $50M on September 10, 2020
Investors: Eventide Asset Management, Third Rock Ventures and The Column Group